Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

mifepristone

mifepristone

19 results

Sort 19 results by:

Filter Applied. Clear All

Latest Posts

October 24, 2025 CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone October 24, 2025 Testimony of CLI Associate Scholar Elizabeth Kirk, J.D. before the Pennsylvania House Judiciary Committee Testimony of CLI Associate Scholar Elizabeth Kirk, J.D. before the Pennsylvania House Judiciary Committee October 21, 2025 The Risks of Abortion Drugs The Risks of Abortion Drugs
Reset All Filters
featured-image
mifepristone

CLI Submits Comment Responding to Washington et al.’s Citizen Petition Requesting FDA Action on Mifepristone

In October 2025, CLI submitted a comment responding to Washington Attorney General Nicholas Brown's citizen petition submitted to the FDA,…

charlotte-lozier-institute Charlotte Lozier Institute
October 24, 2025
Please login to bookmark Close
mifepristone

CLI Submits Comments to 3 Citizen Petitions Requesting FDA Action on Mifepristone

In July to August 2025, the Charlotte Lozier Institute submitted three comments responding to three citizen petitions submitted to the…

featured-image
mifepristone

Fact Sheet: Deficiencies Affecting U.S. Abortion Data Collection and Application

This fact sheet summarizes some of the main ways U.S. abortion data, including complications and abortion-related mortality data, is currently…

featured-image
mifepristone

The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone

This paper systematically examines, and refutes, claims to the effect that the abortion drug mifepristone is as safe as Tylenol…

mifepristone

Filed: CLI Amicus Brief in National Institute of Family and Life Advocates v. Bonta

Attorney General of California, Rob Bonta, has recently targeted pregnancy centers in the state for offering information about the abortion…

mifepristone

Primer: The Basic Biochemistry of Abortion Pill Reversal

This primer lays out the science behind Abortion Pill Reversal by examining the function of progesterone as a naturally occurring…

featured-image
mifepristone

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article…

featured-image
mifepristone

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image